Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $12.2 Million - $16.5 Million
-22,300 Closed
0 $0
Q1 2022

Sep 21, 2023

BUY
$595.12 - $698.43 $13.3 Million - $15.6 Million
22,300 New
22,300 $15.6 Million
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $6.84 Million - $8.03 Million
11,500 Added 106.48%
22,300 $15.6 Million
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $369,798 - $543,873
-1,100 Reduced 9.24%
10,800 $5.27 Million
Q4 2019

Feb 13, 2020

BUY
$274.13 - $376.51 $2.38 Million - $3.28 Million
8,700 Added 271.88%
11,900 $4.47 Million
Q3 2019

Nov 13, 2019

SELL
$273.46 - $318.39 $5.69 Million - $6.62 Million
-20,800 Reduced 86.67%
3,200 $888,000
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $7.19 Million - $9.96 Million
24,000 New
24,000 $7.51 Million
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $1.85 Million - $2.22 Million
-5,500 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$351.14 - $408.51 $1.9 Million - $2.21 Million
5,400 Added 5400.0%
5,500 $2.22 Million
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $1.85 Million - $2.24 Million
-6,500 Reduced 98.48%
100 $34,000
Q1 2018

May 15, 2018

SELL
$315.82 - $393.78 $1.11 Million - $1.38 Million
-3,500 Reduced 34.65%
6,600 $2.27 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $3.44 Million - $4.51 Million
9,600 Added 1920.0%
10,100 $3.8 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $215,690 - $252,000
500
500 $224,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.